Source record
Matching a cancer chart to trial eligibility
The source is Tempus’s company website, dated in this index as 1 April 2025, read as a vendor description of trial matching. Flatiron and Deep 6 AI are named as other companies that sell a version of the same job. The page is not an independent study of enrollment. No enrollment rate or days-saved figure is repeated, because those claims are vendor-specific and often omit how many suggestions a coordinator rejects.
- Source date
- Apr 1, 2025 · Year 2025
- Evidence label
- Vendor-reported
- Source type
- Vendor
Citation
Tempus
Tempus. Company website, dated in this index as 1 April 2025. https://www.tempus.com/ Vendor description of clinical data and trial services. Flatiron and Deep 6 AI are named only as other companies selling trial-matching tools. Not an enrollment study.
Key public facts
- The cited source is a vendor website, not a peer-reviewed enrollment study.
- The tool reads structured fields and sometimes free text, and lists studies a patient might qualify for.
- A research coordinator still checks every criterion against the chart.
- A match list is not enrollment and not a treatment recommendation.
- No enrollment-rate or speed figure is stated.
Directory entry for education and market scanning. Not medical advice and not an endorsement.